Drug interactions
Indacaterol-glycopyrronium + Oxybutynin transdermal
Severity: Moderate
Indacaterol-glycopyrronium and Oxybutynin transdermal: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxybutynin is an antimuscarinic, and even by the transdermal route it provides systemic exposure that can add to the effects of glycopyrronium. Patients may experience more dry mouth, constipation, urinary retention and blurred vision.
What this interaction means in plain words
Indacaterol-glycopyrronium and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive antimuscarinic receptor blockade.
What to do
Monitor for anticholinergic adverse effects, especially in older adults and those with glaucoma or urinary retention. Consider stopping one agent if symptoms occur.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Frequently asked questions
Can I take Indacaterol-glycopyrronium with Oxybutynin transdermal?
MediHelp rates the interaction as moderate. Indacaterol-glycopyrronium and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxybutynin is an antimuscarinic, and even by the transdermal route it provides systemic exposure that can add to the effects of glycopyrronium. Patients may experience more dry mouth, constipation, urinary retention and blurred vision.
How serious is the interaction between Indacaterol-glycopyrronium and Oxybutynin transdermal?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic adverse effects, especially in older adults and those with glaucoma or urinary retention. Consider stopping one agent if symptoms occur.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
